FDA issued a Warning Letter to Nostrum Laboratories Inc on 4/27/2009 for a previous inspection.
483 Nostrum Labs Feb 2014

483 Nostrum Labs Feb 2014

Shirley Berryman FDA, Zachary Bogorad FDA, Susanna Ford FDA, Daniel Hurt FDA$119.00 - Available Now

FDA investigators audited the Nostrum Labs - Kansas City, MO, United States facility and issued inspectional observations (via FDA 483) on 19 Feb 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Feb 2014
  • Location: Kansas City, United States
  • FEI: 1930436
Add To Cart